Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2234 Neoplasms 2039 Lung Neoplasms 1097 Colorectal Neoplasms 1036 Prostatic Neoplasms 894 Carcinoma, Non-Small-Cell Lung 752 Carcinoma, Hepatocellular 674 Stomach Neoplasms 607 Pancreatic Neoplasms 602 Head and Neck Neoplasms 434 Ovarian Neoplasms 430 Colonic Neoplasms 423 Rectal Neoplasms 406 Uterine Cervical Neoplasms 403 Esophageal Neoplasms 347 Brain Neoplasms 329 Neoplasm Metastasis 324 Melanoma 306 Multiple Myeloma 304 Precursor Cell Lymphoblastic Leukemia-Lymphoma 293 Urinary Bladder Neoplasms 290 Leukemia, Myeloid, Acute 278 Lymphoma 268 Liver Neoplasms 253 Endometrial Neoplasms 253 Hematologic Neoplasms 252 Disease 244 Recurrence 225 Glioma 218 Carcinoma, Renal Cell 207

Interventions

fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Hypoxic Tumours × Clear all

NCT00756691 2017-11-14

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

AHS Cancer Control Alberta

Hypoxic Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡